Colonic carcinogenesis in IBD: molecular events

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Patients with ulcerative colitis (UC) and Crohn's disease (CD) have an elevated risk of intestinal cancers.
• Chronic gastrointestinal inflammation is linked to cancer development, with distinct pathways in UC compared to sporadic colorectal cancer.

Purpose of the Study:

• To elucidate the mechanisms linking chronic inflammation in UC to carcinogenesis.
• To identify early molecular events and potential immunosurveillance mechanisms in UC-associated cancer.

Main Methods:

• Analysis of molecular events in UC carcinogenesis, including DNA methylation, p53 mutations, aneuploidy, and microsatellite instability.
• Investigation of epigenetic modifications like hypermethylation of tumor suppressor genes.
• Assessment of p53 mutation frequencies in dysplasia and cancer.
• Evaluation of aneuploidy as a risk factor.
• Examination of co-stimulatory molecule CD80 expression in colonic mucosa.

Main Results:

• UC carcinogenesis involves early events such as DNA methylation leading to tumor suppressor gene silencing, p53 mutations (33-95%), and aneuploidy.
• Hypermethylation of promoter regions in tumor suppressor and DNA mismatch repair genes is an early epigenetic event.
• Aneuploidy is an independent risk factor for carcinogenesis in UC.
• Co-stimulatory molecule CD80 up-regulation in colonic mucosa during UC dysplasia suggests a potential immunosurveillance mechanism.

Conclusions:

• The sequence of molecular events in UC-associated carcinogenesis differs from sporadic colorectal cancer.
• Epigenetic alterations and genetic mutations (p53) play critical roles in early stages of UC carcinogenesis.
• Mechanisms of immunosurveillance, potentially involving CD80, may prevent malignant progression in some UC patients.